publication date: Jan. 24, 2014


CL40-04c.html

The Susan G. Komen Breast Cancer Foundation reported a 22 percent decline in contributions in fiscal 2013—totalling over $77 million—in recent financial statements.

Overall, the charity’s revenues fell by 18 percent from the 2012 fiscal year.

The world’s leading breast cancer advocacy group collected $325 million in the most recent fiscal year, compared to $339 million in fiscal 2012. Komen operates on a budget that ends in March; its 2013 fiscal year began April 1, 2012.

Observers attribute the drop in contributions to the controversy over Komen’s funding of Planned Parenthood (The Cancer Letter, Feb. 3, 2012).

Participation in Komen’s 2012 fundraisers declined in cities nationwide. In Washington, D.C., participation in the 2012 Race for the Cure dropped by as much as 30 percent compared to the year before (The Cancer Letter, June 8, 2012).

“We had additional issues from our reputational issues in 2012,” Komen spokesperson Andrea Rader said to The Cancer Letter. “I don’t think we can quantify it. We’ve asked the question ourselves many times.”

The controversy was one among many factors that affected Komen’s revenues, she said.

“We’ve got issues that everybody else had,” Rader said. “It’s a tough environment and the economic uncertainty in the past couple years certainly had an impact on our profits, of course.

“Since about 2008, since the market crashed and the recession began, we’ve seen a softening, especially since 2010,” Rader said. “So we can’t say X percent is … Continue reading 40-04 Cancer Advocacy

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.